Kawasaki MATCH Trial (NCT07291245) | Clinical Trial Compass
RecruitingNot Applicable
Kawasaki MATCH Trial
United States200 participantsStarted 2025-03-01
Plain-language summary
Evaluating the impact of a machine-learning clinical decision support tool on provider practice when evaluating febrile patients with Kawasaki Disease (KD) and non-KD illnesses.
Who can participate
Age range30 Days – 17 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Measured or subjective fever for \>= 3 calendar days
* One measured fever \>= 38.0 C (home or in ED)
* One or more clinical feature of Kawasaki Disease including:
* Rash
* Conjunctival injection
* Oropharyngeal changes
* Extremity changes (erythema, edema, desquamation)
* Cervical adenopathy (\>=1.5cm)
* Infants \< 6 months of age with \>= 7 days of fever eligible even if none of the above clinical features
* Requires IV/phlebotomy for clinical evaluation
Exclusion Criteria:
* Congenital or Acquired Immune function
* Genetic disorders
* Current systemic steroid, immunosuppression, or chemotherapy treatment (not including inhaled steroids)
What they're measuring
1
Time to Kawasaki Disease treatment (KD patients only)